Reconstructed Skin Models Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Reconstructed Skin Models Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Reconstructed Skin Models Market

The reconstructed skin models market size was valued at USD 32.6 million in 2023, and the market is now projected to grow from USD 35.7 million in 2024 to USD 84.1 million by 2032, exhibiting a CAGR of 13.0% during the forecast period of 2024-2032.

Pandemic negatively impacted the market for reconstructed pores and skin models due to decreased call for among healthcare researchers and delivery chain disruptions. Manufacturers struggled with supply chain issues, hindering studies and improvement. Pharmaceutical corporations and agreement research agencies shifted cognizance to COVID-19 vaccines, reducing demand for those fashions. However, in 2021, eased lockdown restrictions allowed R&D activities amongst cosmeceutical and chemical businesses, helping demand. The growing awareness on growing new cosmetic and cosmeceutical products is predicted to fuel market enlargement.

The call for opportunity skin tissue models in cosmeceutical and pharmaceutical merchandise is growing due to the ban on animal checking out, moral concerns, and boundaries of animal models. This has caused the development of superior reconstructed pores and skin tissue models, fostering marketplace growth. Key players just like the U.S. FDA are focusing on non-animal trying out fashions for in-vitro trying out. The demand is expected to fuel reconstructed skin models market growth.

The marketplace is experiencing a surge in call for superior pores and skin models, main to the development of progressive technology and solutions. The cognizance on increasing R&D spending is a key fashion, with pharmaceutical and cosmeceutical corporations favouring advanced in-vitro fashions. Small-scale research laboratories and agreement manufacturing companies are also shifting toward non-animal models for testing cosmetics and products. Technological advancements also are leading to the improvement of organ-on-a-chip fashions, providing a microfluidic environment for cellular growth.

Comprehensive Analysis of Reconstructed Skin Models Market

The market for reconstructed skin models is divided into reconstructed human epidermis (RHE) and reconstructed human skin (RHS). The RHE segment is dominated by its ease of development and increasing adoption. The RHS segment is expected to grow significantly due to increased awareness and availability of all three layers of skin for product safety and efficacy testing. The market is further divided into skin corrosion, skin irritation, sensitization, skin biopsy, radioallergosorbent, and skin pigmentation tests. Skin irritation tests are expected to grow due to their ability to predict potential chemicals causing skin damage. Skin corrosion, sensitization, and skin biopsy segments are expected to grow due to the growing prevalence of skin cancer and other skin disorders. The end user segment for reconstructed skin models is segmented into cosmetics & cosmeceutical companies, chemical companies, and medical device companies. The growth of these segments is driven by strict regulatory guidelines, the ability of skin tissue models to mimic, and the increasing number of clinical laboratories contributing to R&D activities in healthcare settings.

The Europe region lead the reconstructed skin models market share by benefitting a market size of USD 15.7 million in 2023 due to the increasing adoption of non-animal testing models for safety and efficacy testing, driven by increased demand in healthcare facilities and research centers.

MatTek Corporation and SkinEthic dominate the reconstructed skin models market, accounting for 70% of 2022's share. Other major players include Henkel AG & Co. KGaA and Japan Tissue Engineering Co., Ltd., while emerging players like LabSkin, GenoSkin, and Alcyomics Ltd. are developing reconstructed skin models to increase brand presence.

EPISKIN introduced the SkinEthic H02E, a reconstructed human esophageal epithelium, in March 2023 to expand its product range.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2030

Base Year 2022

Estimated Year 2023

Forecast Period 2023-2030

Historical Period 2019-2021

Growth Rate CAGR of 13.0% from 2023 to 2030

Unit Value (USD Million)

Segmentation By Type

Reconstructed Human Epidermis (RHE)

Reconstructed Human Skin (RHS)

By Application

Skin Corrosion Test

Skin Irritation Test

Skin Sensitization Test

Skin Biopsy

Radioallergosorbent Test

Skin Pigmentation Test

Others

By End User

Cosmetics & Cosmeceutical Companies

Chemical Companies

Others

By Region

U.S. (By Type, By Application, and By End User)

Europe (By Type, By Application, By End User, and By Country/Sub-region)

U.K.

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific (By Type, By Application, By End User, and By Country/Sub-region)

China

Japan

India

Australia

Rest of Asia Pacific

Rest of the World (By Type, By Application, and By End User)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.